X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Piramal Healthcare with MYLAN INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs MYLAN (US) - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PIRAMAL ENTERPRISES   MYLAN
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-16
MYLAN
Dec-14
PIRAMAL ENTERPRISES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,0653,992-   
Low Rs8052,813-   
Sales per share (Unadj.) Rs383.01,366.6-  
Earnings per share (Unadj.) Rs55.1164.6-  
Cash flow per share (Unadj.) Rs74.1265.0-  
Dividends per share (Unadj.) Rs17.500-  
Dividend yield (eoy) %1.90-  
Book value per share (Unadj.) Rs719.9679.3-  
Shares outstanding (eoy) m172.56378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x2.42.5 98.0%   
Avg P/E ratio x17.020.7 82.1%  
P/CF ratio (eoy) x12.612.8 98.3%  
Price / Book Value ratio x1.35.0 25.9%  
Dividend payout %31.80-   
Avg Mkt Cap Rs m161,3441,287,436 12.5%   
No. of employees `0003.825.0 15.1%   
Total wages/salary Rs m16,8980-   
Avg. sales/employee Rs Th17,472.620,683.4 84.5%   
Avg. wages/employee Rs Th4,466.90-   
Avg. net profit/employee Rs Th2,512.82,491.7 100.8%   
INCOME DATA
Net Sales Rs m66,099517,086 12.8%  
Other income Rs m2,425-3,014 -80.4%   
Total revenues Rs m68,524514,072 13.3%   
Gross profit Rs m18,723128,602 14.6%  
Depreciation Rs m3,27437,978 8.6%   
Interest Rs m9,38822,304 42.1%   
Profit before tax Rs m8,48565,306 13.0%   
Minority Interest Rs m3-268 -1.2%   
Prior Period Items Rs m1,5930-   
Extraordinary Inc (Exp) Rs m4570-   
Tax Rs m1,0322,746 37.6%   
Profit after tax Rs m9,50662,291 15.3%  
Gross profit margin %28.324.9 113.9%  
Effective tax rate %12.24.2 289.2%   
Net profit margin %14.412.0 119.4%  
BALANCE SHEET DATA
Current assets Rs m47,488454,587 10.4%   
Current liabilities Rs m104,362355,396 29.4%   
Net working cap to sales %-86.019.2 -448.6%  
Current ratio x0.51.3 35.6%  
Inventory Days Days4178 52.0%  
Debtors Days Days51107 47.7%  
Net fixed assets Rs m26,532119,626 22.2%   
Share capital Rs m34518,286 1.9%   
"Free" reserves Rs m114,0240-   
Net worth Rs m124,221257,042 48.3%   
Long term debt Rs m75,812383,996 19.7%   
Total assets Rs m308,3561,035,343 29.8%  
Interest coverage x1.93.9 48.5%   
Debt to equity ratio x0.61.5 40.9%  
Sales to assets ratio x0.20.5 42.9%   
Return on assets %6.18.2 75.0%  
Return on equity %7.724.2 31.6%  
Return on capital %10.013.6 73.1%  
Exports to sales %17.20-   
Imports to sales %6.60-   
Net fx Rs m9,2530-   
CASH FLOW
From Operations Rs m-67,77367,971 -99.7%  
From Investments Rs m-8,768-53,604 16.4%  
From Financial Activity Rs m76,199-17,910 -425.4%  
Net Cashflow Rs m-342-3,543 9.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 66.98 Rs / USD

Compare PIRAMAL ENTERPRISES With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare PIRAMAL ENTERPRISES With: AJANTA PHARMA  SUN PHARMA  ORCHID PHARMA LTD  UNICHEM LAB  AUROBINDO PHARMA  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Aug 17, 2017 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS